Norway· NO-ID_04DAB56D-1C34-45E3-8368-02D679AB3F29

Syntocinon

A oxytocin product containing oxytocin, registered in Norway by Viatris. The same ATC class is registered in 16 of our 19 countries.

ATC H01BB02

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedSyntocinonATCH01BB02REGISTER NO.NO-ID_04DAB56D-1C34-4…PACKS LISTED3CHECKEDSeptember 25, 2026

Where it is registered

Oxytocin is registered in 16 of 19 countries.

Countries holding a registration under ATC H01BB02 (oxytocin), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 9 of them publish a price we can compare per daily dose

Oxytocin · ATC H01BB02

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Oxytocin
Manufacturer
Viatris
Country
Norway (NO)
ATC code
H01BB02
ATC class
Oxytocin
Defined daily dose
15 E, N
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 3

  • no_merkevare_id
    ID_04DAB56D-1C34-45E3-8368-02D679AB3F29
  • no_varenummer
    325622
    5
  • gtin
    8051499762483

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

303 interactions on record for oxytocin.

Graded by severity as the source publishes them — 71 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Oxytocin · interactions on record

303 records

  • 71 severe
  • 228 moderate
  • 3 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • QuinidineC01BA01severe

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Oxytocin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All oxytocin products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Oxytocin Grindeks, Syntocinon
  • Belgium · Oxytocin Grindeks, Syntocinon
  • Bulgaria · Окситоцин Pихtep
  • Cyprus · Syntocinon
  • Czechia · Ofost, Oxytocin Avmc
  • Germany · Oxytocin Hexal, Oxytocin Panpharma
  • Denmark · Oxytocin Orifarm, Syntocinon
  • Estonia · Oxytocin Grindeks
  • Spain · Oxitocina Grindeks, Syntocinon
  • Finland · Oxytocin Orifarm, Syntocinon
  • France · Oxytocine Ever Pharma, Oxytocine Grindeks
  • United Kingdom (Northern Ireland) · Oxytocin, Oxytocin Hameln Pharma
  • Greece · Oxytocin Gap
  • Croatia · Syntocinon
  • Hungary · Oxytocin Grindeks, Oxytocin Panpharma
  • Ireland · Ofost, Oxytocin Pinewood Laboratories
  • Iceland · Syntocinon
  • Italy · Ossitocina Grindeks, Syntocinon
  • Lithuania · Ofost, Oxytocin Grindeks
  • Latvia · Ofost, Oxytocin Grindeks
  • Malta · Oxytocin Wockhardt, Syntocinon
  • Netherlands · Syntocinon
  • Poland · Oxytocin Grindeks, Oxytocin Grindex
  • Portugal · Oxitocina Generis, Oxitocina Grindeks
  • Romania · Ofost, Oxitocină Panpharma
  • Sweden · Oxytocin Cd Pharma, Oxytocin Grindeks
  • Slovenia · Ofost, Syntocinon
  • Slovakia · Ofost, Oxygrindeks

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ba0d975e-1420-404b-8d69-a0d33cd5a0b1
GET /v1/drugs/ba0d975e-1420-404b-8d69-a0d33cd5a0b1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Nesespray, oppløsning",
  "source": "fest",
  "status": "A",
  "atc_name": "Oksytocin",
  "merkevare_id": "ID_04DAB56D-1C34-45E3-8368-02D679AB3F29",
  "name_form_strength": "Syntocinon nesespray oppl 6,7 mikrog/dose",
  "prescription_group": "C"
}

See everything about oxytocin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.